tiprankstipranks
Trending News
More News >
U.s. Physical Therapy (USPH)
NYSE:USPH
US Market
Advertisement

US Physical Therapy (USPH) Ratios

Compare
100 Followers

US Physical Therapy Ratios

USPH's free cash flow for Q2 2025 was $0.25. For the 2025 fiscal year, USPH's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.18 2.28 1.30 1.14 0.94
Quick Ratio
1.18 2.28 1.33 1.14 0.94
Cash Ratio
0.29 1.50 0.37 0.34 0.35
Solvency Ratio
0.13 0.09 0.16 0.23 0.34
Operating Cash Flow Ratio
0.60 0.80 0.68 0.92 1.07
Short-Term Operating Cash Flow Coverage
1.46 10.66 1.41 2.44 3.09
Net Current Asset Value
$ -273.48M$ -111.63M$ -262.32M$ -201.82M$ -96.75M
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.26 0.34 0.30 0.19
Debt-to-Equity Ratio
0.61 0.54 0.94 0.75 0.40
Debt-to-Capital Ratio
0.38 0.35 0.48 0.43 0.29
Long-Term Debt-to-Capital Ratio
0.23 0.23 0.36 0.39 0.22
Financial Leverage Ratio
2.36 2.09 2.72 2.54 2.15
Debt Service Coverage Ratio
1.45 3.66 1.35 2.18 1.90
Interest Coverage Ratio
8.42 7.48 9.83 81.50 32.08
Debt to Market Cap
0.15 0.11 0.21 0.18 0.07
Interest Debt Per Share
20.67 18.88 23.19 17.37 8.77
Net Debt to EBITDA
2.68 1.42 3.47 2.27 1.01
Profitability Margins
Gross Profit Margin
20.37%18.52%20.25%23.67%22.33%
EBIT Margin
11.94%9.70%11.09%14.98%15.88%
EBITDA Margin
15.24%12.30%13.76%17.32%18.37%
Operating Profit Margin
11.10%11.50%10.27%15.51%12.39%
Pretax Profit Margin
10.62%8.16%10.05%14.79%15.49%
Net Profit Margin
4.76%2.43%7.85%11.70%12.41%
Continuous Operations Profit Margin
8.04%6.15%7.85%11.70%12.41%
Net Income Per EBT
44.85%29.72%78.11%79.14%80.12%
EBT Per EBIT
95.63%70.99%97.83%95.34%124.99%
Return on Assets (ROA)
2.69%1.47%5.06%7.73%8.83%
Return on Equity (ROE)
6.43%3.08%13.75%19.60%19.01%
Return on Capital Employed (ROCE)
6.96%7.77%7.35%11.53%10.46%
Return on Invested Capital (ROIC)
5.04%5.59%5.23%8.35%7.49%
Return on Tangible Assets
9.71%3.88%17.00%25.36%27.28%
Earnings Yield
2.36%1.11%4.13%4.70%3.40%
Efficiency Ratios
Receivables Turnover
10.09 11.66 10.65 10.70 10.09
Payables Turnover
126.12 126.43 67.82 58.39 246.08
Inventory Turnover
0.00 0.00 -154.35 377.84M 328.52M
Fixed Asset Turnover
2.57 4.67 4.33 4.15 4.10
Asset Turnover
0.56 0.61 0.64 0.66 0.71
Working Capital Turnover Ratio
30.76 7.71 29.53 169.85 44.60
Cash Conversion Cycle
33.30 28.41 26.52 27.87 34.68
Days of Sales Outstanding
36.19 31.30 34.27 34.12 36.16
Days of Inventory Outstanding
0.00 0.00 -2.36 <0.01 <0.01
Days of Payables Outstanding
2.89 2.89 5.38 6.25 1.48
Operating Cycle
36.19 31.30 31.90 34.12 36.16
Cash Flow Ratios
Operating Cash Flow Per Share
4.72 5.78 4.51 5.92 7.79
Free Cash Flow Per Share
4.01 5.12 3.87 5.29 7.20
CapEx Per Share
0.71 0.66 0.64 0.64 0.60
Free Cash Flow to Operating Cash Flow
0.85 0.89 0.86 0.89 0.92
Dividend Paid and CapEx Coverage Ratio
1.61 2.45 1.98 2.83 8.51
Capital Expenditure Coverage Ratio
6.61 8.82 7.10 9.32 13.09
Operating Cash Flow Coverage Ratio
0.23 0.32 0.20 0.34 0.90
Operating Cash Flow to Sales Ratio
0.11 0.14 0.11 0.15 0.24
Free Cash Flow Yield
4.52%5.50%4.78%5.53%5.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
42.46 90.06 24.24 21.28 29.40
Price-to-Sales (P/S) Ratio
2.02 2.18 1.90 2.49 3.65
Price-to-Book (P/B) Ratio
2.69 2.78 3.33 4.17 5.59
Price-to-Free Cash Flow (P/FCF) Ratio
22.11 18.18 20.92 18.07 16.71
Price-to-Operating Cash Flow Ratio
18.76 16.12 17.97 16.13 15.43
Price-to-Earnings Growth (PEG) Ratio
8.41 -1.46 -0.95 2.18 -3.30
Price-to-Fair Value
2.69 2.78 3.33 4.17 5.59
Enterprise Value Multiple
15.95 19.19 17.29 16.64 20.87
Enterprise Value
1.62B 1.43B 1.32B 1.43B 1.62B
EV to EBITDA
15.95 19.19 17.29 16.64 20.87
EV to Sales
2.43 2.36 2.38 2.88 3.83
EV to Free Cash Flow
26.57 19.64 26.17 20.92 17.56
EV to Operating Cash Flow
22.55 17.41 22.48 18.68 16.22
Tangible Book Value Per Share
-5.77 2.32 -9.11 -5.32 0.63
Shareholders’ Equity Per Share
32.95 33.56 24.32 22.92 21.52
Tax and Other Ratios
Effective Tax Rate
0.24 0.25 0.22 0.21 0.20
Revenue Per Share
43.77 42.63 42.60 38.38 32.95
Net Income Per Share
2.08 1.03 3.34 4.49 4.09
Tax Burden
0.45 0.30 0.78 0.79 0.80
Interest Burden
0.89 0.84 0.91 0.99 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.09 0.08 0.09 0.10
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.02 0.02
Income Quality
1.44 2.20 1.35 1.32 1.90
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis